Literature DB >> 1990765

Is hyperglycemia associated with cardiovascular disease? The Framingham Study.

P W Wilson1, L A Cupples, W B Kannel.   

Abstract

The association of nonfasting blood glucose levels with CVD incidence was determined prospectively in 1382 men and 2094 women aged 45 to 84 years participating in the Framingham Heart Study. For this study, all patients were classified in 1970 as diabetic or nondiabetic. Every 2 years they were examined, categorized according to causal blood glucose samples obtained at the clinic visit, reclassified for development of CVD and diabetes mellitus, and followed 10 years for CVD. During the follow-up period, 350 men and 369 women developed CVD. Age-adjusted CVD rates were positively associated with glucose levels in nondiabetic women who did not develop diabetes during follow-up. No such associations were seen in men. Multivariate analyses confirmed the independent association of blood glucose levels with later CVD in nondiabetic women. This study shows that hyperglycemia in the original Framingham cohort is an independent risk factor for CVD in nondiabetic women, but not among men.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1990765     DOI: 10.1016/0002-8703(91)90729-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  20 in total

Review 1.  Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Authors:  Toni Terry; Kalyani Raravikar; Nalurporn Chokrungvaranon; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

2.  Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

Authors:  I M Stratton; C A Cull; A I Adler; D R Matthews; H A W Neil; R R Holman
Journal:  Diabetologia       Date:  2006-05-31       Impact factor: 10.122

3.  [Cardiovascular risk and the new diagnostic categories for diabetes mellitus proposed by the American Diabetes Association].

Authors:  J Baena Díez; J Martínez Martínez; B Alvarez Pérez; J Tomàs Pelegrina; P Piñol Forcadell; E Raidó Quintana; M Oller Colom; A Hidalgo García
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

4.  Post-meal coagulation activation in diabetes mellitus: the effect of acarbose.

Authors:  A Ceriello; C Taboga; L Tonutti; R Giacomello; L Stel; E Motz; M Pirisi
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 5.  Beneficial and detrimental effects of intensive glycaemic control, with emphasis on type 2 diabetes mellitus.

Authors:  P Camacho; S Pitale; C Abraira
Journal:  Drugs Aging       Date:  2000-12       Impact factor: 3.923

6.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

7.  Effect on central obesity and associated disturbances of low-energy, fruit- and vegetable-enriched prudent diet in north Indians.

Authors:  R B Singh; M A Niaz; S Ghosh
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

8.  Mortality in Older Persons with Retinopathy and Concomitant Health Conditions: The Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Diana E Fisher; Fridbert Jonasson; Ronald Klein; Palmi V Jonsson; Gudny Eiriksdottir; Lenore J Launer; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2016-04-07       Impact factor: 12.079

9.  Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries.

Authors:  A MacKenzie; E J Cooper; F J Dowell
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

10.  Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes.

Authors:  G Hu
Journal:  Diabetologia       Date:  2003-05-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.